Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Keflex
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Keflex 250mg capsules
0501021L0BCAAAA
|
Keflex | Cefalexin | Infections | 5 |
|
Keflex 500mg tablets
0501021L0BCADAH
|
Keflex | Cefalexin | Infections | 4 |
|
Keflex 250mg tablets
0501021L0BCACAG
|
Keflex | Cefalexin | Infections | 3 |
|
Keflex 125mg/5ml oral suspension
0501021L0BCAEAC
|
Keflex | Cefalexin | Infections | No data available |
|
Keflex 250mg/5ml oral suspension
0501021L0BCAFAD
|
Keflex | Cefalexin | Infections | No data available |
|
Keflex 500mg capsules
0501021L0BCABAB
|
Keflex | Cefalexin | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.